中国肺癌杂志2022，Vol.25Issue(5)：323-336,14.DOI:10.3779/j.issn.1009-3419.2022.104.01
Treatment Sequencing Strategies in Lung Cancer
Treatment Sequencing Strategies in Lung Cancer
Daniel Humberto Pozza 1Ramon Bezerra Andrade de Mello2
作者信息
- 1. Department of Biomedicine,Faculty of Medicine and i3s,University of Porto,4200-319 Porto,Portugal
- 2. Discipline of Medical Oncology,Post-graduation Program in Medicine,Nine of July University(UNINOVE),S?o Paulo,Brazil./Nine of July Hospital,S?o Paulo,Brazil
- 折叠
摘要
关键词
Lung neoplasms/Immunotherapy/Clinical trials/Targeted therapies/Pembrolizumab/Nivolumab/Atezolizumab/Necitumumab/BrigatinibKey words
Lung neoplasms/Immunotherapy/Clinical trials/Targeted therapies/Pembrolizumab/Nivolumab/Atezolizumab/Necitumumab/Brigatinib引用本文复制引用
Daniel Humberto Pozza,Ramon Bezerra Andrade de Mello..Treatment Sequencing Strategies in Lung Cancer[J].中国肺癌杂志,2022,25(5):323-336,14.
